Literature DB >> 21570957

Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen.

Ryan D Kinloch1, Choon-Myung Lee, Nico van Rooijen, Edward T Morgan.   

Abstract

Hepatic cytochrome P450 (P450) gene and protein expression are modulated during inflammation and infection. Oral infection of C57BL/6 mice with Citrobacter rodentium produces mild clinical symptoms while selectively regulating hepatic P450 expression and elevating levels of proinflammatory cytokines. Here, we explored the role of cytokines in the regulation of hepatic P450 expression by orally infecting tumor necrosis factor-α (TNFα) receptor 1 null mice (TNFR1-/-), interleukin-1 (IL1) receptor null mice (IL1R1-/-), and Kupffer cell depleted mice with C. rodentium. CYP4A mRNA and protein levels and flavin monooxygenase (FMO)3 mRNA expression levels were down-regulated, while CYP2D9 and CYP4F18 mRNAs remained elevated during infection in wild-type, receptor knockout, and Kupffer cell depleted mice. CYPs 3A11 and 3A25 mRNA levels were down-regulated during infection in wild-type mice but not in TNFR1-/- mice. Consistent with this observation, CYPs 3A11 and 3A25 were potently down-regulated in mouse hepatocytes treated with TNFα. Oral infection of IL1R1-/- mice and studies with mouse hepatocytes indicated that IL1 does not directly regulate CYP3A11 or CYP3A25 expression. Uninfected mice injected with clodronate liposomes had a significantly reduced number of Kupffer cells in their livers. Infection increased the Kupffer cell count, which was attenuated by clodronate treatment. The P450 mRNA and cytokine levels in infected Kupffer cell depleted mice were comparable to those in infected mice receiving no clodronate. The results indicate that TNFα is involved in the regulation of CYPs 3A11 and 3A25, but IL1β and Kupffer cells may not be relevant to hepatic P450 regulation in oral C. rodentium infection.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570957      PMCID: PMC3124565          DOI: 10.1016/j.bcp.2011.04.016

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  36 in total

1.  Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice.

Authors:  Terrilyn A Richardson; Edward T Morgan
Journal:  J Pharmacol Exp Ther       Date:  2005-04-28       Impact factor: 4.030

2.  Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice.

Authors:  Terrilyn A Richardson; Melanie Sherman; Leposava Antonovic; Sean S Kardar; Henry W Strobel; Daniel Kalman; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2005-12-08       Impact factor: 3.922

3.  Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease.

Authors:  L M Higgins; G Frankel; G Douce; G Dougan; T T MacDonald
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 4.  Regulation of drug-metabolizing enzymes and transporters in inflammation.

Authors:  Alison E Aitken; Terrilyn A Richardson; Edward T Morgan
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

5.  Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation.

Authors:  Kerry B Goralski; Dalya Abdulla; Christopher J Sinal; Andre Arsenault; Kenneth W Renton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-05-05       Impact factor: 4.052

Review 6.  Regulation of drug metabolism and disposition during inflammation and infection.

Authors:  Kenneth W Renton
Journal:  Expert Opin Drug Metab Toxicol       Date:  2005-12       Impact factor: 4.481

7.  Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration.

Authors:  G W Warren; S M Poloyac; D S Gary; M P Mattson; R A Blouin
Journal:  J Pharmacol Exp Ther       Date:  1999-03       Impact factor: 4.030

8.  Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium.

Authors:  Sarah L Lebeis; Kimberly R Powell; Didier Merlin; Melanie A Sherman; Daniel Kalman
Journal:  Infect Immun       Date:  2008-12-15       Impact factor: 3.441

9.  Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.

Authors:  Alison E Aitken; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2007-06-18       Impact factor: 3.922

10.  Regulation of hepatic drug-metabolizing enzyme genes by Toll-like receptor 4 signaling is independent of Toll-interleukin 1 receptor domain-containing adaptor protein.

Authors:  Romi Ghose; Damara White; Tao Guo; Jesus Vallejo; Saul J Karpen
Journal:  Drug Metab Dispos       Date:  2007-10-11       Impact factor: 3.922

View more
  9 in total

Review 1.  Drug disposition in pathophysiological conditions.

Authors:  Adarsh Gandhi; Bhagavatula Moorthy; Romi Ghose
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

2.  Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes.

Authors:  Beatrice A Nyagode; Ifor R Williams; Edward T Morgan
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

3.  Selective modulation of hepatic cytochrome P450 and flavin monooxygenase 3 expression during citrobacter rodentium infection in severe combined immune-deficient mice.

Authors:  Beatrice A Nyagode; William J Watkins; Ryan D Kinloch; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2012-06-27       Impact factor: 3.922

4.  Selective and cytokine-dependent regulation of hepatic transporters and bile acid homeostasis during infectious colitis in mice.

Authors:  Matthew D Merrell; Beatrice A Nyagode; John D Clarke; Nathan J Cherrington; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2013-12-30       Impact factor: 3.922

Review 5.  The Role of Cytochrome P450 Enzymes in COVID-19 Pathogenesis and Therapy.

Authors:  Guyi Wang; Bing Xiao; Jiayi Deng; Linmei Gong; Yi Li; Jinxiu Li; Yanjun Zhong
Journal:  Front Pharmacol       Date:  2022-02-02       Impact factor: 5.810

6.  Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: Implications for disease-dependent drug-drug interactions.

Authors:  Beatrice A Nyagode; Roya Jahangardi; Matthew D Merrell; Malú G Tansey; Edward T Morgan
Journal:  Pharmacol Res Perspect       Date:  2014-02-01

7.  Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis.

Authors:  Arzu Ataseven; Recep Kesli; Gulcan Saylam Kurtipek; Perihan Ozturk
Journal:  Dis Markers       Date:  2014-04-02       Impact factor: 3.434

Review 8.  Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.

Authors:  Françoise Stanke-Labesque; Elodie Gautier-Veyret; Stephanie Chhun; Romain Guilhaumou
Journal:  Pharmacol Ther       Date:  2020-07-11       Impact factor: 12.310

9.  NF-κB-mediated regulation of rat CYP2E1 by two independent signaling pathways.

Authors:  Qin Lin; Xiaolin Kang; Xuefeng Li; Tao Wang; Fengting Liu; Jinxue Jia; Ziqi Jin; Yongzhi Xue
Journal:  PLoS One       Date:  2019-12-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.